Drug data last refreshed 17h ago · AI intelligence enriched 3w ago
OPHTHOCORT is a fixed-dose combination ophthalmic ointment containing chloramphenicol (antibiotic), hydrocortisone acetate (corticosteroid), and polymyxin B sulfate (antibiotic). It is indicated for bacterial eye infections with inflammatory components. The combination provides broad-spectrum antimicrobial coverage plus anti-inflammatory action for acute and chronic ocular infections.
As a legacy product approaching loss of exclusivity, the brand faces moderate competitive pressure (30/100) with likely declining revenue and a minimal or defensive commercial team structure.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on OPHTHOCORT offers limited career upside due to its mature, off-patent lifecycle and minimal linked job openings (0 identified). Roles are primarily defensive, focused on market maintenance and revenue protection rather than growth or innovation. This is a stable but low-trajectory assignment best suited for early-career professionals or lateral moves seeking operational experience.
Worked on OPHTHOCORT at Pfizer? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.